High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome.
about
Domain V peptides inhibit beta2-glycoprotein I-mediated mesenteric ischemia/reperfusion-induced tissue damage and inflammation.Anti-β2-glycoprotein I paratopes and β2-glycoprotein I epitopes characterization using random peptide libraries.Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays.Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.Increased intrathecal high-avidity anti-tau antibodies in patients with multiple sclerosis.Increased Performances of the Biological Diagnosis of the Antiphospholipid Syndrome by the Use of a Multiplex AssayInteractions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis.Detection of antiphosphatidylserine/prothrombin antibodies and their potential diagnostic value.European Forum on Antiphospholipid Antibodies: research in progress.Optimization of unnicked β2-glycoprotein I and high avidity anti-β2-glycoprotein I antibodies isolation.Antiphospholipid syndrome: A diagnostic challenge.Thrombomodulatory Effect of Anti-B2-Glycoprotein I Antibodies on Crystalline Annexin A5 on Phospholipid Bilayers, as Observed by Atomic Force Microscopy.Rational Laboratory Diagnostics of Antiphospholipid Antibodies: Anti-Cardiolipin, Anti-β2-Glycoprotein I, Anti-Prothrombin and Anti-Annexin V Antibodies.Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritis.Avidity of onconeural antibodies is of clinical relevance.Oxidatively altered IgG with increased immunoreactivity to β2-glycoprotein I and its peptide clusters influence human coronary artery endothelial cells.Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome?Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells.
P2860
Q34401715-CB8213D0-5E08-412B-9FE6-4836784630BFQ35167094-3A046F1E-4DDA-4613-B110-F4B4595D7387Q35194106-CFCA7638-CBA3-4C70-9196-314267B3D656Q35419865-F7FACBBE-E86C-469D-A8E0-4405096BAAAEQ35580278-B2224115-4EEE-49A6-8C2B-8190DC8DC7CDQ35625927-28FF0E7E-E091-4E6C-BF2F-8F2B3001D36DQ36387401-DCF45464-0CCD-49ED-8DA6-45897DE71D3BQ37244052-FA09D3DC-D3BE-4207-8C52-11ECCDDD25DBQ37578126-56845D44-F1BC-48E1-BE54-043778AB9ADDQ37704570-A1086882-9A42-43F0-A850-2A15C351C762Q39066464-20862C62-F698-4699-BEDE-9E308713CFA7Q42378451-1ADD5132-1E44-4B60-958F-30215634A23DQ42378680-50B7FE50-1D34-4C0F-A23C-13C2784C7F00Q45771233-0E0C434B-3B9F-4C64-9830-224D1918886FQ45924953-2BE0667D-CD2C-4D58-A05B-0C54FED8A26CQ50940120-5C47A1F1-BAA8-4AA0-9427-EDF02936C1A7Q50943891-CA774972-0A1E-429E-A9DC-15BA32D99B96Q53203652-596DC0B5-A712-465F-9134-99BDBB5D2E7DQ53695989-C87FA915-28E3-487A-BC5F-E3A951DCC5EC
P2860
High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
High avidity anti-beta 2-glyco ...... ith antiphospholipid syndrome.
@ast
High avidity anti-beta 2-glyco ...... ith antiphospholipid syndrome.
@en
type
label
High avidity anti-beta 2-glyco ...... ith antiphospholipid syndrome.
@ast
High avidity anti-beta 2-glyco ...... ith antiphospholipid syndrome.
@en
prefLabel
High avidity anti-beta 2-glyco ...... ith antiphospholipid syndrome.
@ast
High avidity anti-beta 2-glyco ...... ith antiphospholipid syndrome.
@en
P2093
P2860
P356
P1476
High avidity anti-beta 2-glyco ...... ith antiphospholipid syndrome.
@en
P2093
P2860
P304
P356
10.1136/ARD.2003.017939
P407
P577
2004-11-01T00:00:00Z